8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Quest Diagnostics Reports Q2 Growth and Raises 2026 Guidance
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics reported second-quarter 2026 revenue of $3.04 billion, up 10.2% year over year, with reported diluted EPS of $2.84 and adjusted diluted EPS of $3.12 for the quarter ended June 30. The company raised its full-year 2026 revenue outlook to $11.95 billion-$12.05 billion, reported diluted EPS guidance to $9.97-$10.17, and adjusted diluted EPS guidance to $11.05-$11.25.